Yang Jiamin, Xu Yi, Dang Hangyu, Han Hengxin
Institute of Biothermal Science and Technology, University of Shanghai for Science and Technology, Shanghai 200093, China.
Shanghai Technical Service Platform for Cryopreservation of Biological Resources, Shanghai 200093, China.
Sheng Wu Gong Cheng Xue Bao. 2022 Jun 25;38(6):2169-2186. doi: 10.13345/j.cjb.210772.
Decellularized extracellular matrix (dECM) is designed to remove cells that cause immune rejection and retain the original tissue structure and composition. Since its structure and composition are similar to the original tissues and organs, it has attracted extensive attention in tissue engineering and biomedicine applications, and has become a promising tissue engineering material. dECM can be easily obtained from tissues and organs by appropriate decellularization methods. Here, we summarized the commonly used decellularization methods and reviewed the sterilization, cross-linking and storage methods of decellularized scaffold. In addition, we summarized the latest applications and developments of dECMs obtained from different tissues/organs in tissue engineering and biomedicine. Finally, we discussed the present challenges of dECM biomaterials and prospected future perspectives. With the development of tissue engineering and regenerative medicine technology, dECM biomaterials are expected to become a gold scaffold in the field of biomedicine and will receive wide applications.
去细胞外基质(dECM)旨在去除引起免疫排斥的细胞,并保留原始的组织结构和成分。由于其结构和组成与原始组织和器官相似,它在组织工程和生物医学应用中引起了广泛关注,并已成为一种有前途的组织工程材料。通过适当的去细胞方法,可以很容易地从组织和器官中获得dECM。在这里,我们总结了常用的去细胞方法,并综述了去细胞支架的灭菌、交联和储存方法。此外,我们总结了从不同组织/器官获得的dECM在组织工程和生物医学中的最新应用和发展。最后,我们讨论了dECM生物材料目前面临的挑战并展望了未来前景。随着组织工程和再生医学技术的发展,dECM生物材料有望成为生物医学领域的黄金支架,并将得到广泛应用。